Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06052514 · ClinicalTrials.gov registry record

CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea

A clinical trial of COVID-19 and Sleep Apnea, sponsored by Venkatesh Krishnamurthy.

Completed
Registry status
22
Enrollment target
1
Study location

NCT06052514 is a study of COVID-19 and Sleep Apnea that has completed, run by Venkatesh Krishnamurthy. The registered enrollment target is 22 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06052514, a study of COVID-19 and Sleep Apnea, has completed, sponsored by Venkatesh Krishnamurthy.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, observational study evaluating the relationship between severity of sleep apnea with severity of cognitive fog and if treatment of sleep apnea with CPAP improves cognitive fog in a cohort of post COVID patients with sleep apnea.

Conditions Studied

Interventions

  • DEVICE Continuous positive airway pressure

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-01-04
Est. Completion 2024-12-31

Sponsor

Venkatesh Krishnamurthy

1 total trials

What the Registry Record Tells You About NCT06052514

The ClinicalTrials.gov registry entry for NCT06052514 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Venkatesh Krishnamurthy, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Continuous positive airway pressure is the first listed.

NCT06052514 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06052514 about?

NCT06052514 is a clinical study titled "CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea". This is a prospective, observational study evaluating the relationship between severity of sleep apnea with severity of cognitive fog and if treatment of sleep apnea with CPAP improves cognitive fog in a cohort of post COVID patients with sleep apnea.

What is the current status of trial NCT06052514?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2024-01-04. Estimated completion is 2024-12-31.

What conditions does trial NCT06052514 study?

This clinical trial studies the following conditions: COVID-19, Sleep Apnea.

What interventions are being tested in trial NCT06052514?

The interventions under investigation include: Continuous positive airway pressure (DEVICE).

Who is sponsoring clinical trial NCT06052514?

This trial is sponsored by Venkatesh Krishnamurthy, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06052514 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.